19 Conversations

Welcome to Health Conversation. Today we're asking Jo Atkinson, Anti-Infectives Product Lead at Pfizer, 'How can we navigate COVID-19 in a new winter health landscape?'. Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.

Welcome to Health Conversation. Today we're asking Claire Skentelbery, Director General of EuropaBio, 'What is the waiver impact on innovation and pandemic preparedness?'. Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.

Welcome to Health Conversation. Today we're asking Koen Berden, Executive Director for International Affairs at EFPIA, 'Why is a therapeutics waiver extension different to the vaccine waiver?'. Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.

Welcome to Health Conversation. Today we're asking Jesús Rueda Rodríguez, Strategies, Special Projects & International Affairs Director General at MedTech Europe, 'What would a TRIPS waiver extension mean for diagnostics?'. Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.

Welcome to Health Conversation. Today we're asking Peter Guenter, CEO of Healthcare at Merck, 'What would be the impact of a TRIPS waiver extension?'. Listen to hear their discussion on the challenge and how we're preparing for the future. Hosted on Acast. See acast.com/privacy for more information.

Welcome to Health Conversation. Today we're asking Nathalie Moll, Director General at EFPIA, 'How can we support medical innovation in Europe?'. Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Sara Cerdas, MEP and Mariano Votta, Director, Active Citizenship Network "How can the EU be better prepared for cross-border health threats?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Michel Stoffel, Senior Adviser Global Regulatory Affairs, GSK and Isabelle Bekeredjian-Ding, Head of Microbiology Division, Paul-Ehrlich-Institut "What is needed from the EMA to be better prepared for future health threats?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Prof. Paolo Bonanni, MD, Professor of Hygiene & Public Health, University of Florence, Prof. Dr Joe Schmitt, Editor in Chief, Global Health Press and Sibilia Quilici, Executive Director, Vaccines Europe "What is needed from the ECDC to be better prepared for future health threats?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Dr Dominik Mumberg, Translational Innovation Lead, Bayer and Dr Mathias Rossberg, VP, Business Unit Head, Oncology & Haematology, Bayer "How is precision medicine transforming cancer care?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Luc Van Steenwinkel, Site Lead, Pfizer Puurs and Vice President Pfizer Biotech Operations, and Danny Hendrikse, Vice President, Pfizer Global Supply Chain, "From raw materials to patients' arms – how are COVID-19 vaccines made?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Lars Fruergaard Jorgensen, President & Chief Executive Officer, Novo Nordisk "How is the pharmaceutical industry contributing to a healthy environment?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Alyna Smith, Senior Advocacy Officer, Platform for International Cooperation on Undocumented Migrants and Boris Azaïs, Director Public Policy Europe Canada, MSD "How can we improve healthcare access for marginalised communities?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Professor Michel Goldman, previous IMI Executive Director and Dr Pierre Meulien, current IMI Executive Director "What value do Public Private Partnerships bring for society?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Nicoletta Luppi, Senior Vice President and Managing Director, MSD Italy "How can vaccines help in Europe's fight against cancer?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Dr Koen Berden, Executive Director for International Trade, EFPIA "Should Europe relocate pharmaceutical production to within the EU?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Dr Janelle Sabo, Global Therapeutics Platform Leader, Eli Lilly and Company "How can monoclonal antibodies help in the fight against COVID-19?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Prof. Dr. Walter Van Dyck, Director of Healthcare Management Centre, Vlerick Business School "Is intellectual property a barrier to access?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Nathalie Moll, Director General of EFPIA, "How can we future-proof medicines regulation in the post-COVID world?". Listen to hear the discussion on this challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Catherine Boudot, Director of the Trademark Department, Servier "Fighting the fakes - what's industry's role?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Chris Skedgel, Director of Health Economics "Can a shared understanding of unmet medical needs support innovation?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Paul Robinson, European Patient Engagement Lead, MSD and Weronika Burkot, Patient Representative, International Diabetes Federation "Has COVID-19 transformed telemedicine forever?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Johanna Mercier, Chief Commercial Officer, Gilead "How is the pharmaceutical industry contributing to the fight against COVID-19?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Thomas Cueni, Director General, International Federation of Pharmaceutical Manufacturers (IFPMA) "Have you dropped the ball on antimicrobial resistance?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking David Jefferys, Senior Vice President for Global Regulatory, Healthcare Policy and Corporate Affairs, Eisai Europe and Chair of EFPIA's Alzheimer's disease platform and Philip Scheltens, Professor of Neurology and Director of the Alzheimer Centre in Amsterdam "Can we expect a cure for Alzheimer's soon?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Jack Scannell, Independent Consultant and Honorary Fellow at the School of Social and Political Science, The University of Edinburgh "Is the pharmaceutical industry making too much money?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Angelika Joos, Executive Director, Global Regulatory Policy, MSD "Can we develop better medicines for children faster?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Elizabeth Hermsen, Head of Global Antimicrobial Stewardship, MSD and Bruce Altevogt, Vice President and Head of External Medical Engagement, Hospital Business Unit, Pfizer "Is industry doing enough to tackle antimicrobial resistance?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Olivier Charmeil, Executive Vice President, General Medicines, Sanofi "How can Europe be better prepared for future pandemics?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Andy Powrie-Smith, Executive Director of Communications & Partnerships, EFPIA "Can the pharmaceutical industry be more transparent?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we’re asking Erik van den Berg, Chief Executive Officer, AM Pharma "How can we keep SMEs in Europe?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Nathalie Moll, Director General, EFPIA "Will the pharmaceutical strategy achieve its aims?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we're asking Dr. Holger Zimmermann, Chief Executive Officer, AiCuris "How does a pharmaceutical SME function?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. Today we’re asking Richard Torbett, Chief Executive, Association of the British Pharmaceutical Industry "Who decides the price of a medicine?". Listen to hear their discussion on the challenge and how we're preparing for the future. See acast.com/privacy for privacy and opt-out information.

Welcome to 19 Conversations. In our first conversation, Jacki Davis asks Mariano Votta, Director of Active Citizenship Network, and Michel Stoffel, Vice-President, Head of Europe Region, Global Regulatory Affairs, GSK Vaccines if vaccines for COVID-19 will be safe. Listen to hear their discussion on the challenge and how we're preparing for the future.Presented by the European Federation of Pharmaceutical Industries and Association See acast.com/privacy for privacy and opt-out information.

Have questions about the healthcare industry? Welcome to 19 Conversations, where we will discuss today’s challenges and how we’re preparing for the future. Presented by the European Federation of Pharmaceutical Industries and Association See acast.com/privacy for privacy and opt-out information.